Quadrivalent Human Papillomavirus Vaccine (4vHPV, GARDASIL®) Fails to Protect Men who Have Anal Sex
By Peter A. McCullough, MD, MPH The quadrivalent human papillomavirus vaccine 4vHPV, GARDASIL® was approved in the US in 2009 for use in males aged 9 to 26 for the prevention of HPV-related genital warts, and in 2010 for the prevention of certain HPV-related anogenital diseases. It is widely used in normal boys and girls […]
Discuss on Nostr!
Nostr Note ID note18j2qz66hy7em9h7scl3zqr690q8fkju9purappry6ez58mdxmyzqc5rlqs Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.